Jazz Pharmaceuticals plc — Director's Dealing 2014

Jul 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-07-08

Reporting Person: Keegan Fintan (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-08	Ordinary Shares	M	469	$46.83	Acquired	33741	Direct
2014-07-08	Ordinary Shares	S	1991	$155.00	Disposed	31750	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-08	Nonstatutory Stock Option (right to buy)	$46.83	M	469	Disposed	2022-08-08	Ordinary Shares (469)	Direct

Footnotes

F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: This option vests over four years from the grant date of August 9, 2012, with 1/4th vested on August 9, 2013 and the remainder vesting in 36 equal monthly installments thereafter.